Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...

Among patients with idiopathic pulmonary fibrosis, the risk for all-cause mortality was significantly lower with vs. without angiotensin-converting enzyme inhibitor use started within 5 years before ...

ACE inhibitor use was associated with reduced all cause mortality in idiopathic pulmonary fibrosis in a matched real world ...

A new large-scale real-world study has found that the use of angiotensin-converting enzyme (ACE) inhibitors may be associated with improved survival in patients with idiopathic pulmonary fibrosis (IPF ...